What is the recommended iron dosage for a 46-year-old female with moderate anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Dosing for Moderate Anemia in a 46-Year-Old Female

For a 46-year-old woman with hemoglobin 9.0 g/dL, prescribe oral iron supplementation at 60-120 mg of elemental iron daily, continuing treatment for 2-3 months after hemoglobin normalizes. 1

Initial Treatment Approach

Start with oral iron therapy at 60-120 mg of elemental iron per day. 1 This is the CDC's recommended dose for treating anemia in nonpregnant women of childbearing age with presumed iron-deficiency anemia.

Practical Dosing with Ferrous Sulfate

  • Each ferrous sulfate 324 mg tablet contains 65 mg of elemental iron 2
  • Administer 1-2 tablets daily (providing 65-130 mg elemental iron) to achieve the recommended 60-120 mg range 2
  • Take tablets whole without crushing or chewing 2
  • Alternative dosing: 100-200 mg elemental iron daily is also supported, with lower doses if side effects occur 3

Concurrent Dietary Counseling

Counsel the patient about correcting iron deficiency through dietary modifications in addition to supplementation. 1 Iron-rich foods and foods that enhance iron absorption should be emphasized.

Follow-Up Protocol

Initial Response Assessment

  • Recheck hemoglobin after 4 weeks of treatment 1
  • Expected response: hemoglobin should increase by at least 1 g/dL 1
  • If no response despite compliance and absence of acute illness, proceed to further evaluation 1

Extended Treatment Duration

Continue iron supplementation for 2-3 months after hemoglobin normalizes to replenish iron stores. 1 This extended duration is critical and distinguishes treatment in women of childbearing age from other populations.

When to Escalate Evaluation

Non-Response Criteria

If anemia persists after 4 weeks of compliant therapy:

  • Order additional laboratory tests: MCV, RDW, and serum ferritin 1
  • Consider hemoglobinopathies (thalassemia minor, sickle cell trait) particularly in women of African, Mediterranean, or Southeast Asian ancestry 1
  • Evaluate for malabsorption (celiac disease, atrophic gastritis), chronic inflammation, or ongoing blood loss 3

Alternative: Intravenous Iron

When to Consider IV Iron

Intravenous iron should be considered if:

  • Oral iron causes intolerable side effects 3
  • Oral therapy lacks efficacy despite compliance 3
  • Intestinal malabsorption is present 3
  • Rapid correction is needed (though less urgent at Hb 9.0 g/dL) 4

IV Iron Dosing Protocol

  • Calculate total iron deficit: Weight (kg) × (Target Hb - Actual Hb) × 2.4 + 500 mg for stores 4
  • Iron sucrose maximum single dose: 200 mg per session, administered IV over 10 minutes 4
  • Dosing schedule: 200 mg twice weekly until total calculated deficit is administered 4
  • Monitor vital signs during and for 30 minutes after infusion due to hypersensitivity risk 4

Common Pitfalls to Avoid

  • Do not stop treatment when hemoglobin normalizes—continue for 2-3 additional months to replenish stores 1
  • Do not assume all anemia is iron-deficiency—confirm diagnosis and evaluate non-responders thoroughly 1, 3
  • Do not overlook underlying causes—investigate for sources of blood loss, malabsorption, or chronic disease 3, 5
  • Oral iron side effects (22-29% incidence) can be mitigated by reducing dose or switching to IV formulation 4, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Sucrose Dosing for Severe Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Iron deficiency anemia: evaluation and management.

American family physician, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.